Nie, David Y. https://orcid.org/0000-0002-6956-0634
Tabor, John R.
Li, Jianping https://orcid.org/0000-0002-3972-1652
Kutera, Maria
St-Germain, Jonathan
Hanley, Ronan P.
Wolf, Esther
Paulakonis, Ethan
Kenney, Tristan M. G. https://orcid.org/0000-0001-8242-4349
Duan, Shili
Shrestha, Suman
Owens, Dominic D. G. https://orcid.org/0000-0001-6194-4636
Maitland, Matthew E. R.
Pon, Ailing
Szewczyk, Magdalena
Lamberto, Anthony Joseph https://orcid.org/0009-0008-2950-0013
Menes, Michael
Li, Fengling
Penn, Linda Z.
Barsyte-Lovejoy, Dalia https://orcid.org/0000-0002-6560-9621
Brown, Nicholas G. https://orcid.org/0000-0002-6141-0164
Barsotti, Anthony M.
Stamford, Andrew W. https://orcid.org/0000-0003-0693-3461
Collins, Jon L. https://orcid.org/0009-0007-8086-1802
Wilson, Derek J. https://orcid.org/0000-0002-7012-6085
Raught, Brian
Licht, Jonathan D. https://orcid.org/0000-0002-3942-1369
James, Lindsey I. https://orcid.org/0000-0002-6034-7116
Arrowsmith, Cheryl H. https://orcid.org/0000-0002-4971-3250
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FDN154328, OGB190363, 494204, PJT156093)
Princess Margaret Cancer Foundation
Fonds de Recherche du Québec - Santé (320128)
UNC | UNC-Chapel Hill | Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (5T32CA217824-05)
Cancer Research Society (25418)
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (RGPIN-480432, CRDPJ-504037)
Leukemia and Lymphoma Society
Florida Department of Health
U.S. Department of Health & Human Services | National Institutes of Health (R01CA242305)
Article History
Received: 31 October 2023
Accepted: 31 May 2024
First Online: 4 July 2024
Competing interests
: D.D.G.O. is an employee of Amphista Therapeutics, a company that is developing TPD therapeutic platforms. A.M.B. and A.W.S. are employees of Deerfield Management Company, a healthcare-focused investment management firm. The remaining authors declare no competing interests.